table of content
1 Introduction to Research & Analysis Reports
1.1 T-Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global T-Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global T-Cell Therapy Overall Market Size
2.1 Global T-Cell Therapy Market Size: 2022 VS 2030
2.2 Global T-Cell Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top T-Cell Therapy Players in Global Market
3.2 Top Global T-Cell Therapy Companies Ranked by Revenue
3.3 Global T-Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 T-Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies T-Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 T-Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 T-Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 T-Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global T-Cell Therapy Market Size Markets, 2022 & 2030
4.1.2 CAR T Cell Therapy
4.1.3 TCR Therapy
4.1.4 TIL Therapy
4.2 By Type - Global T-Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global T-Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global T-Cell Therapy Revenue, 2024-2030
4.2.3 By Type - Global T-Cell Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global T-Cell Therapy Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics & Ambulatory Centers
5.1.4 Cancer Research Institutes
5.1.5 Others
5.2 By Application - Global T-Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global T-Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global T-Cell Therapy Revenue, 2024-2030
5.2.3 By Application - Global T-Cell Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global T-Cell Therapy Market Size, 2022 & 2030
6.2 By Region - Global T-Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global T-Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global T-Cell Therapy Revenue, 2024-2030
6.2.3 By Region - Global T-Cell Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America T-Cell Therapy Revenue, 2018-2030
6.3.2 US T-Cell Therapy Market Size, 2018-2030
6.3.3 Canada T-Cell Therapy Market Size, 2018-2030
6.3.4 Mexico T-Cell Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe T-Cell Therapy Revenue, 2018-2030
6.4.2 Germany T-Cell Therapy Market Size, 2018-2030
6.4.3 France T-Cell Therapy Market Size, 2018-2030
6.4.4 U.K. T-Cell Therapy Market Size, 2018-2030
6.4.5 Italy T-Cell Therapy Market Size, 2018-2030
6.4.6 Russia T-Cell Therapy Market Size, 2018-2030
6.4.7 Nordic Countries T-Cell Therapy Market Size, 2018-2030
6.4.8 Benelux T-Cell Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia T-Cell Therapy Revenue, 2018-2030
6.5.2 China T-Cell Therapy Market Size, 2018-2030
6.5.3 Japan T-Cell Therapy Market Size, 2018-2030
6.5.4 South Korea T-Cell Therapy Market Size, 2018-2030
6.5.5 Southeast Asia T-Cell Therapy Market Size, 2018-2030
6.5.6 India T-Cell Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America T-Cell Therapy Revenue, 2018-2030
6.6.2 Brazil T-Cell Therapy Market Size, 2018-2030
6.6.3 Argentina T-Cell Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa T-Cell Therapy Revenue, 2018-2030
6.7.2 Turkey T-Cell Therapy Market Size, 2018-2030
6.7.3 Israel T-Cell Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia T-Cell Therapy Market Size, 2018-2030
6.7.5 UAE T-Cell Therapy Market Size, 2018-2030
7 T-Cell Therapy Companies Profiles
7.1 Gilead Sciences, Inc.
7.1.1 Gilead Sciences, Inc. Company Summary
7.1.2 Gilead Sciences, Inc. Business Overview
7.1.3 Gilead Sciences, Inc. T-Cell Therapy Major Product Offerings
7.1.4 Gilead Sciences, Inc. T-Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Gilead Sciences, Inc. Key News & Latest Developments
7.2 Sorrento Therapeutics
7.2.1 Sorrento Therapeutics Company Summary
7.2.2 Sorrento Therapeutics Business Overview
7.2.3 Sorrento Therapeutics T-Cell Therapy Major Product Offerings
7.2.4 Sorrento Therapeutics T-Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Sorrento Therapeutics Key News & Latest Developments
7.3 Fate Therapeutics Inc.
7.3.1 Fate Therapeutics Inc. Company Summary
7.3.2 Fate Therapeutics Inc. Business Overview
7.3.3 Fate Therapeutics Inc. T-Cell Therapy Major Product Offerings
7.3.4 Fate Therapeutics Inc. T-Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Fate Therapeutics Inc. Key News & Latest Developments
7.4 Novartis International AG
7.4.1 Novartis International AG Company Summary
7.4.2 Novartis International AG Business Overview
7.4.3 Novartis International AG T-Cell Therapy Major Product Offerings
7.4.4 Novartis International AG T-Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 Novartis International AG Key News & Latest Developments
7.5 AbbVie Inc.
7.5.1 AbbVie Inc. Company Summary
7.5.2 AbbVie Inc. Business Overview
7.5.3 AbbVie Inc. T-Cell Therapy Major Product Offerings
7.5.4 AbbVie Inc. T-Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 AbbVie Inc. Key News & Latest Developments
7.6 Adaptimmune Therapeutics PLC
7.6.1 Adaptimmune Therapeutics PLC Company Summary
7.6.2 Adaptimmune Therapeutics PLC Business Overview
7.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Major Product Offerings
7.6.4 Adaptimmune Therapeutics PLC T-Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 Adaptimmune Therapeutics PLC Key News & Latest Developments
7.7 Bluebird Bio
7.7.1 Bluebird Bio Company Summary
7.7.2 Bluebird Bio Business Overview
7.7.3 Bluebird Bio T-Cell Therapy Major Product Offerings
7.7.4 Bluebird Bio T-Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 Bluebird Bio Key News & Latest Developments
7.8 TCR2 Therapeutics, Inc.
7.8.1 TCR2 Therapeutics, Inc. Company Summary
7.8.2 TCR2 Therapeutics, Inc. Business Overview
7.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Major Product Offerings
7.8.4 TCR2 Therapeutics, Inc. T-Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 TCR2 Therapeutics, Inc. Key News & Latest Developments
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Company Summary
7.9.2 Pfizer Inc. Business Overview
7.9.3 Pfizer Inc. T-Cell Therapy Major Product Offerings
7.9.4 Pfizer Inc. T-Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 Pfizer Inc. Key News & Latest Developments
7.10 DiaCarta, Inc.
7.10.1 DiaCarta, Inc. Company Summary
7.10.2 DiaCarta, Inc. Business Overview
7.10.3 DiaCarta, Inc. T-Cell Therapy Major Product Offerings
7.10.4 DiaCarta, Inc. T-Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 DiaCarta, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
